BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32505877)

  • 1. Adherence to standards of care and mortality in the management of Staphylococcus aureus bacteraemia in Peru: A prospective cohort study.
    Schwalb A; Cachay R; de la Flor A; García C; Seas C
    Int J Infect Dis; 2020 Jul; 96():601-606. PubMed ID: 32505877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
    Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
    Yaw LK; Robinson JO; Ho KM
    Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
    Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study.
    Seas C; Garcia C; Salles MJ; Labarca J; Luna C; Alvarez-Moreno C; Mejía-Villatoro C; Zurita J; Guzmán-Blanco M; Rodríguez-Noriega E; Reyes J; Arias CA; Carcamo C; Gotuzzo E;
    J Antimicrob Chemother; 2018 Jan; 73(1):212-222. PubMed ID: 29045648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus aureus bacteraemia in children and neonates: a 10 year retrospective review.
    Denniston S; Riordan FA
    J Infect; 2006 Dec; 53(6):387-93. PubMed ID: 16476482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors of methicillin-resistance and their impact on mortality associated with Staphylococcus aureus bacteraemia.
    Wi YM; Rhee JY; Kang CI; Chung DR; Song JH; Peck KR
    Epidemiol Infect; 2018 Jul; 146(10):1326-1336. PubMed ID: 29781425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
    Paul M; Kariv G; Goldberg E; Raskin M; Shaked H; Hazzan R; Samra Z; Paghis D; Bishara J; Leibovici L
    J Antimicrob Chemother; 2010 Dec; 65(12):2658-65. PubMed ID: 20947620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.
    Nagao M; Yamamoto M; Matsumura Y; Yokota I; Takakura S; Teramukai S; Ichiyama S
    Infection; 2017 Feb; 45(1):83-91. PubMed ID: 27709434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
    Ammerlaan H; Seifert H; Harbarth S; Brun-Buisson C; Torres A; Antonelli M; Kluytmans J; Bonten M;
    Clin Infect Dis; 2009 Oct; 49(7):997-1005. PubMed ID: 19719417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
    Rasmussen JB; Knudsen JD; Arpi M; Schønheyder HC; Benfield T; Ostergaard C
    J Antimicrob Chemother; 2014 Feb; 69(2):506-14. PubMed ID: 24078468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management and outcomes of Staphylococcus aureus bacteraemia at a South African referral hospital: A prospective observational study.
    Steinhaus N; Al-Talib M; Ive P; Boyles T; Bamford C; Davies MA; Mendelson M; Wasserman S
    Int J Infect Dis; 2018 Aug; 73():78-84. PubMed ID: 29908251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores.
    Kim SH; Park WB; Lee CS; Kang CI; Bang JW; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
    Clin Microbiol Infect; 2006 Jan; 12(1):13-21. PubMed ID: 16460541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
    Nissen JL; Skov R; Knudsen JD; Ostergaard C; Schønheyder HC; Frimodt-Møller N; Benfield T
    J Antimicrob Chemother; 2013 Aug; 68(8):1894-900. PubMed ID: 23599360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge.
    Wolkewitz M; Frank U; Philips G; Schumacher M; Davey P;
    J Antimicrob Chemother; 2011 Feb; 66(2):381-6. PubMed ID: 21098543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.
    Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H
    Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia.
    Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Warren SJ; Gao W; Johnson PD; Howden BP
    Clin Microbiol Infect; 2013 Dec; 19(12):1163-8. PubMed ID: 23441652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival following Staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care.
    Nambiar K; Seifert H; Rieg S; Kern WV; Scarborough M; Gordon NC; Kim HB; Song KH; Tilley R; Gott H; Liao CH; Edgeworth J; Nsutebu E; López-Cortés LE; Morata L; Walker AS; Thwaites G; Llewelyn MJ; Kaasch AJ;
    J Infect; 2018 Dec; 77(6):516-525. PubMed ID: 30179645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study.
    Smith JR; Frens JJ; Snider CB; Claeys KC
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):50-54. PubMed ID: 29153470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.